30/05/2019 10:00:00

Amarin to Present at the Jefferies 2019 Healthcare Conference

BEDMINSTER, N.J., and DUBLIN, Ireland, May 30, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's president and chief executive officer, is scheduled to present a general company update at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019, at 9:30 a.m. Eastern Time in New York City.

A live audio webcast of the presentation will be available at: https://www.amarincorp.com, and will be accessible at the same link for 30 days.

About Amarin

Amarin Corporation plc. is a rapidly growing, innovative pharmaceutical company focused on developing therapeutics to improve cardiovascular health. Amarin’s product development program leverages its extensive experience in polyunsaturated fatty acids and lipid science. Vascepa® (icosapent ethyl) is Amarin's first FDA-approved drug and is available by prescription in the United States, Lebanon and the United Arab Emirates.  Amarin’s commercial partners are pursuing additional regulatory approvals for Vascepa in Canada, China and the Middle East. For more information about Amarin, visit www.amarincorp.com.

Availability of other Information about Amarin

Investors and others should note that Amarin communicates with its investors and the public using the company website (https://www.amarincorp.com/), the investor relations website (https://investor.amarincorp.com/), including but not limited to investor presentations and investor FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts.  The information that Amarin posts on these channels and websites could be deemed to be material information.  As a result, Amarin encourages investors, the media, and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis.  This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels.  The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Amarin Contact Information

Investor Relations:

Elisabeth Schwartz

Investor Relations and Corporate Communications

Amarin Corporation plc

In U.S.: +1 (908) 719-1315

investor.relations@amarincorp.com

Lee M. Stern

Solebury Trout

In U.S.: +1 (646) 378-2992

lstern@soleburytrout.com

Amarin Corporation plc Logo

Related content
19 Jul - 
Amarin Prices Public Offering of American Depositary Sh..
17 Jul - 
Amarin Announces $400,000,000 Public Offering of Americ..
02 Jul - 
Amarin Provides Mid-2019 Update, Including Commercializ..
Related debate
10 Aug - 
Sikke en røvfuld AMRN fik i går, da FDA defacto fjerned..
06 Aug - 
På trods af en stor stigning sidste år, er der stadigvæ..
01 Aug - 
En af analytikerne hedder Louise Chen... https://financ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Industry Welcomes Second-Generation Low Emission Methanol-Fuelled Vessels
2
True Nature Holding Announces A Private Offering Under Rule 506(C) Of Its New Series A, 10% Cumulative Redeemable Perpetual Preferred Stock Offering
3
GDOT INVESTOR ALERT: Hagens Berman Investigating Possible Disclosure Violations by Green Dot Corporation (GDOT), Encourages Investors Who Lost $50,000+ to Contact the Firm
4
CADE INVESTIGATION UPDATE: Hagens Berman Reminds Cadence Bancorp. (CADE) Investors of Ongoing Investigation
5
CARB Investor Alert: Hagens Berman Reminds Carbonite, Inc. (CARB) Investors of September 30, 2019 Lead Plaintiff Deadline

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 August 2019 13:18:10
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB2 - 2019-08-21 14:18:10 - 2019-08-21 13:18:10 - 1000 - Website: OKAY